About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
With 7,000 medicines in development across the globe, strong trade agreements are vital to facilitating global access to innovative treatments and fueling tomorrow’s new medicines and cures. The renegotiated U.S.-Mexico-Canada Agreement (USMCA) strengthens patent and other intellectual property (IP) protections for American medical innovations and raises market access and regulatory standards across North America.
PhRMA USMCA image
Fact Sheet
Trade
PhRMA USMCA
PhRMA USMCA image